OBJECTIVES: Left ventricular free wall rupture (LVFWR) is a catastrophic complication following acute myocardial infarction with an estimated incidence of 0.2-7.6% and mortality can be as high as 60%. This study aimed to identify the risk factors for morbidity and mortality in patients affected by LVFWR.
INTRODUCTION
Mechanical complications following acute myocardial infarction (AMI) may involve the interventricular septum, the ventricular free wall or the papillary muscles. Left ventricular free wall rupture (LVFWR) is the most common mechanical complication, occurring up to 10 times more frequently [1] . LVFWR is a rare, unpredictable and often fatal post-AMI complication. Despite demonstrated improved clinical outcomes, post-AMI LVFWR with an incidence of 0.2-7.6% [2] [3] [4] still accounts for 24-61% of in-hospital disease-related mortality [2, 3, 5, 6] . Traditionally viewed as a disease with higher female and older age (>60 years) predisposition [6] , LVFWR is associated with first incidence of acute trans-mural myocardial infarction and/or related myocardial ischaemic symptoms, no mural thrombus and mild or no left ventricular hypertrophy [7, 8] .
Because of the rarity of this post-AMI lethal complication, optimal evidence-based therapeutic strategy remains controversial, and little is known on the early clinical results and late follow-up.
This current retrospective study was designed to review our surgical experience with LVFWR and to identify risk factors for morbidity and mortality. Moreover, long-term survival was also reviewed.
METHODS
This retrospective cohort study reports all cases of LVFWR diagnosed and managed surgically at the Department of Cardiac Surgery, San Gerardo Teaching Hospital for 17 years, from January 2000 to December 2016. Although 3 authors (G.S., N.J. and O.A.B.) are working in 3 different centres, this is not a multiinstitutional study. According to the early clinical outcomes in terms of in-hospital mortality, patients were divided into 2 groups: survivors (n = 23) and non-survivors (n = 12). The study was approved by the Institutional Review and Ethics Board of San Gerardo Teaching Hospital, and the requirement for individual patient consent was waived. Clinical records were thoroughly reviewed and individual data sheets carefully compiled.
A definitive diagnosis in all the cases was based on the evidence of pericardial effusion or cardiac tamponade on transthoracic or transoesophageal echocardiography, alongside physical examination and electrocardiography findings.
Surgical technique
The initial anaesthetic and surgical protocol was essentially the same for all the patients. Left ventricular repair was achieved by 4-0 polypropylene sutures with supporting Teflon pledgets (direct suture technique) or by the autologous or synthetic pericardial patch (TachoSil; Nycomed, Linz, Austria) and glue (Bioglue CryoLife, Inc., Kennesaw, GA, USA) ('patch-and-glue' technique) whose cardiac rupture was of the 'oozing' type. Operations were performed either on cardiopulmonary bypass and cardioplegic arrest or on beating heart according to the haemodynamic status, the type of rupture or the need for additive surgical procedure. Sometimes the repair was performed using extracorporeal membrane oxygenation (ECMO) in those patients requiring mechanical support before surgery. The ECMO circuit and management were already described [9, 10] . In brief, the permanent life support ECMO circuit loop consists of a Quadrox-D oxygenator and a centrifugal pump Rotaflow (Maquet, Jostra Medizintechnik AG, Hirrlingen, Germany). Venoarterial peripheral femoral cannulation was used in all patients previous to heparin administration (5000 IU). Mechanical ventilation was continued throughout ECMO support with same management for every patient. Right and left arterial lines were always monitored for upper body syndrome (i.e. Harlequin or North-South Syndrome), which can occur in the setting of poor lung function but good myocardial contractility [11, 12] . No attempt to wean off ECMO was considered during the first 48 h.
Step-by-step approach is our main strategy for weaning ECMO using transoesophageal echocardiography monitoring. If the haemodynamics remained stable with no addition of inotropes, then heparin was stopped and cannulas were removed at the bedside within the next few hours.
Statistical analysis
All statistical analyses were performed with SPSS v.24.0 (Statistical Package for Social Science, SPSS Inc., Chicago, IL, USA). All descriptive values were expressed as mean with standard deviation. Categorical values, expressed as percentage, were compared using the Pearson's v 2 test. Group outcome differences were compared with the Student's t-test for independent samples. Variables that achieved a P-value <0.01 in the univariable analysis were examined using multivariable analysis by forward stepwise logistic regression to evaluate independent risk factors for in-hospital mortality. Survival analysis was performed using the Kaplan-Meier analysis. The date of last follow-up was 20 February 2017 for all survived patients and the date of death for patients who died during follow-up. Long-term outcome was all-cause mortality. All-cause mortality is the most robust and unbiased index, because inaccurate or biased clinical documentation or assessments are avoided [13] . Information about death was obtained from the Regional Institutional Health Database System for all patients. A P-value <0.05 was considered statistically significant.
RESULTS

Clinical characteristics
Thirty-five patients (25 men; 71.4%) with a mean age of 68.3 ± 8.5 years (range 51-84 years) were treated with emergent surgery for LVFWR. Pre-existing hypertension (65.7%) was the most common comorbidity, followed by smoking history (40%). The interval between AMI and LVFWR diagnosis was 2.6 ± 3.3 days, and the interval between LVFWR and the operation was 14.7 ± 20.7 h. Ten (28.6%) patients underwent surgery after an interval of 10 h and 13 (37.1%) patients from 5 to 10 h. Pericardial tamponade was present in 29 (82.9%) patients. No patient presented with pericardial effusion without sign or pericardial tamponade. Among the 12 patients presented with cardiogenic shock, only 1 patient had no pericardial tamponade or effusion. As presented in Table 1 , 22 (62.9%) patients had preoperative intra-aortic balloon pump (IABP) and/or ECMO, whereas 4 (11.4%) patients were supported with both ECMO and IABP. Among the 12 patients requiring preoperative ECMO, 11 (91.7%) patients experienced pericardial tamponade at presentation. Of the 35 patients, 12 (34.3%) patients presented with cardiac arrest, which was the main haemodynamic status at presentation in non-survivors compared with survivors (75% vs 13%, respectively; P = 0.007). Pre-existing hypertension, cardiopulmonary resuscitation (CPR) before surgery and preoperative ECMO were more significantly prevalent in non-survivors. Before surgery, 27 (77.1%) patients underwent coronary angiogram. Percutaneous coronary revascularization was performed in 9 (25.7%) patients, 6 (26.1%) patients in survivors group and 3 (25%) patients in nonsurvivors group (P = 0.94). The left ventricular artery was revascularized in 7 (77.7%) patients, and the culprit vessel for the LVFWR was revascularized in 5 (55.5%) patients. Among the 15 patients who underwent coronary artery bypass grafting (CABG), 7 (46.6%) patients had the culprit lesion grafted. We found no differences between the 2 groups with respect to the interval between the diagnosis of AMI and LVFWR and the interval between the onset of LVFWR symptoms and surgery (Table 1) .
In 8 (22.9%) patients, the operation was performed on beating heart without cardiopulmonary bypass, 21 (60%) patients were operated using cardiopulmonary bypass and 6 (17.1%) patients using ECMO. No patients had concomitant pseudoaneurysm. Active bleeding ('blowout' rupture type) from the area of infarction was observed in 19 (54.3%) patients, whereas in 16 (45.7%) patients, the rupture was 'oozing' type. Concomitantly, an overall 17 additive surgical procedures were performed: isolated CABG was performed in 15 patients and mitral valve repair or replacement was performed in 5 patients. One Bentall operation and 1 ventricular septal defect closure were associated with LVFWR repair in 2 patients with an increased complexity of the LVFWR repair operation (Table 2) . Twelve patients were assisted by ECMO before the surgical operation.
Rupture site
The exact rupture site was identified intraoperatively. In our LVFWR cohort, 15 (42,959) patients had rupture laterally located, 10 (28.6%) patients inferiorly, 6 (17.1%) patients anteriorly and 4 (11.4%) patients posteriorly (Table 3 ). There was no appreciable difference in the left ventricle function and ejection fraction between the 2 groups (Table 1) . Blowout-type cardiac rupture was identified in 16 (45.7%) patients. In the remaining patients, LVFWR was an oozing-type rupture. Blowout rupture had the highest rate of presentation in patients with inferior wall rupture (n = 7; 43.8%), whereas oozing rupture was mainly present in patients with lateral wall rupture (n = 10; 55.6%). There was a significant difference between survivors and non-survivors in terms of blowout rupture type (34.8% vs 66.7%, respectively; P = 0.017).
Early outcomes
In-hospital survival was 65.7% (n = 23), 13% of patients presented with cardiac arrest. Table 4 lists the perioperative and postoperative characteristics. The mean intensive care unit stay of the survivors was 11.3 days. There were no significant differences between survivors and non-survivors in terms of surgical reexploration for bleeding or tamponade (26.1% vs 25%; P = 0.94), blood transfusion (65.2% vs 75%; P = 0.55), postoperative IABP (30.4% vs 25%; P = 0.73), CABG (52.2% vs 41.7%; P = 0.47), mechanical ventilation time (P = 0.83) and intensive care unit stay (P = 0.31). A significant difference was observed in the use of ECMO during the postoperative period in non-survivors compared with survivors (66.7% vs 13%, respectively; P = 0.001). Univariable analysis identified the associations between inhospital mortality and pre-existing hypertension (P = 0.02), CPR at presentation (P = 0.004), preoperative ECMO (P = 0.004), cardiac arrest at presentation (P < 0.0001), need for inotropes at presentation (P = 0.020), technique of left ventricle repair (P = 0.013), operation on ECMO (P = 0.005), need for postoperative ECMO (P = 0.001) and postoperative use of IABP and/or ECMO (P = 0.024). Multivariable analysis identified only cardiac arrest at presentation as an independent predictor of in-hospital mortality (odds ratio 11.7, 95% confidence interval 2.352-59.063; P = 0.003).
The overall mean duration of postoperative hospitalization was 15.6 ± 18.1 days (range 0-95 days).
Cause of in-hospital mortality included brain death (n = 5), brain death and bowel ischaemia (n = 2), multiorgan failure (n = 2), septic shock (n = 1), cardiac arrest (n = 1) and huge, irreparable myocardial rupture (n = 1). Four of the 5 patients who died secondary to brain death and 2 patients who died because of a combination of brain death and bowel ischaemia were supported with ECMO preoperatively.
Follow-up
Follow-up was complete in 100% of patients who survived surgery. The average follow-up period was 12.6 ± 1.3 years (range 0.2-16.4 years) for the 23 survivors. Figure 1 shows the Kaplan-Meier estimate of overall survival (OS) including non-survivors. The overall average follow-up was 8.3 ± 1.3 years with a cumulative 576 patient-years. OS rates at 5 and 10 years were 53.2 ± 8.6% and 49.1 ± 8.9%, respectively. Among the survivor patients, only 6 (26.1%) patients died during the follow-up with a 5-year and 10-year OS rate of 80.9 ± 8.7% and 74.7 ± 10%, respectively (Fig. 2) . We could not observe any significant difference between the 5-year and 10-year survival rates in comparison with the blowout versus oozing rupture type (5 years: 68.8 ± 11.6% vs 73.7 ± 10.1%, respectively; 10 years: 37.5 ± 12.1% vs 68 ± 10.8%, respectively; P = 0.14).
DISCUSSION
Post-AMI LVFWR is an infrequent but a lethal complication with an estimated incidence ranging from 0.2% to 7.6% and relatively high disease-related mortality [3, 4, 14, 15] . Our cohort represents approximately 1.9% of all CABG operations performed in patients presented with a coronary acute syndrome (n= 1853) within the study period; although we acknowledge that due to an unknown contribution of out-of-hospital sudden death, the true incidence of LVFWR may have been higher than observed and managed herein. Thus, this report represents a relatively large single-centre LVFWR management experience.
The main findings of this study included the following: (i) betterthan-anticipated in-hospital survival of this often fatal post-AMI complication, (ii) acceptable long-term survival and (iii) cardiac arrest and CPR being the worst outcome.
Despite significant evolution of the pathophysiological basis of myocardial rupture, and improvement in diagnostic as well as therapeutic strategy, according to the Global Registry of Acute Coronary Events, as many as 80% of all in-hospital mortality is LVFWR related and occur during perioperative hospital stay [3, 16] . In our study, we noted a male preponderance, contrary to the traditional view of higher female predisposition and old age (>60 years) predilection [6] , and association with lateral or anterior trans-mural AMI, mild or no left ventricular hypertrophy and pre-existing hypertension [6, 7, [17] [18] [19] . Our findings are in concordance with previous reports that the classical clinical manifestations of LVFWR are dependent on the rate of pericardial bleeding and consequent pericardial tamponade, often manifesting within the 1st week post-AMI [1, 19] . Our observations corroborate O'Rourke's [20] seminal work that delineated this rupture type as acute and noted that this rupture type did not permit time for therapeutic intervention. However, about a third of LVFWR cases were subacute in nature, characterized by localized small myocardial lesions with recurrent mild bleeding, allowing some time for emergent surgical repair [20, 21] . LVFWR may present as 'blowout' or 'oozing', where the former is most often associated with haemodynamic instability and/or cardiac arrest, whereas the latter is self-limiting, with varying severity. In the oozing subtype, episodes of increased systemic arterial blood pressure and myocardial contractility contribute to bleeding; it is not usually associated with cardiogenic shock [22] . In this study, we found that blowout is associated with a higher in-hospital mortality rate compared with oozing because of rapid pericardial effusion accumulation and consequent cardiogenic shock and/or cardiac arrest at presentation (65.2% vs 34.8%).
Moreover, we observed that preoperative cardiogenic shock or cardiac arrest that necessitated ECMO increased the risk of death significantly. The same trend was observed in the case of postoperative low cardiac output that required ECMO support. However, the results of this study did not provide any evidence to support any benefit of perioperative ECMO on in-hospital survival. Six of the 8 non-survivors supported with ECMO died from brain death, and for these patients, it was not possible to evaluate potential weaning and the clinical efficacy of ECMO.
In our study group, the main reason for brain death could be attributable to the long no-flow time (>5 min) and a long lowflow time (>60 min) before ECMO initiation. All these patients had pericardial tamponade at presentation complicated with cardiac arrest, and they underwent ECMO peripheral cannulation during CPR. Moreover, focusing on the intrinsic mechanism of the peripheral ECMO used in our facility, it is probable that the retrograde flow of ECMO from the femoral-aortic cannula competing with the weak cardiac output of the failing heart results inadvertently in increased left ventricular wall tension/ myocardial stress, which leads to compromised oxygenation of coronary blood supplies, thereby nullifying or attenuating the intended survival benefit of ECMO. In the setting of this oftenfatal complication of AMI, ECMO support therapy does not appear to definitively improve survival and should be reserved for carefully selected patients.
Our in-hospital survival rate was 65.7%, which is consistent with the 38-78% in-hospital survival rate seen in previous studies [4, 5, [23] [24] [25] [26] [27] . The wide range of survival rate reported in previous studies is probably reflective of different presentation rates of the 2 types of cardiac rupture. Haddadin et al. [26] reported an inhospital survival of 64% (11 of 15 patients) in blowout type rupture and an 88% (7 of 8 patients) in-hospital survival in oozing rupture. The overall in-hospital survival was 73.7%. The same trend is reported in our study, where we found a higher in-hospital survival rate in patients presented with oozing LVFWR with respect to blowout type (63.4% vs 36.4%, respectively).
In this study, the overall mean follow-up duration was 8.3 years, with 5-year and 10-year OS rates of 53% and 49%, respectively. To the best of our knowledge, this represents the longest follow-up period for any single-centre LVFWR report in the literature. Sakaguchi et al. [23] reported a 5-year survival rate of 74% and a mean follow-up of 29 months (2.4 years) in a series of 32 patients with LVFWR. Their cohort had only 4 patients who underwent direct suture repair because of blowout LVFWR. The higher 5-year survival compared with our findings may be due to a lower number of patients requiring CPR at presentation (25%) and a higher number of patch and glue repair, whose survival trend is higher than direct suture repair. Zoffoli et al. [24] reported a mean follow-up duration of 6.7 years, with an overall mortality rate at late follow-up of 32% (8 of 32 patients). In their cohort, no patients required any form of preoperative mechanical circulatory support, and perhaps, haemodynamics at presentation was not as severely compromised as in our study. However, in our study, it is interesting to highlight that when survival function is limited to survivor patients, 5-year survival is 81% and 10-year survival approaches 75%. We could not demonstrate in our cohort a beneficial effect of additive CABG. We can postulate that the real effectiveness of the myocardial revascularization is underestimated by the low number of patients requiring CABG. Furthermore, in emergency situations, the execution of a coronary angiogram examination is not always possible due to the need to quickly proceed with surgery. This could contribute to the likely relative low incidence of coronary artery bypass procedure associated with repair of the left ventricle. Finally, because the lack of literature data about this issue does not allow us to confirm whether the addition of CABG surgery can improve the short-term clinical outcomes, it is always advisable to proceed with a coronary angiogram, according to the haemodynamics at presentation to obtain a complete myocardial revascularization, where necessary. Furthermore, we did not find any statistically significant difference in terms of inhospital mortality in patients who underwent LVFWR repair and an associated surgical procedure. We can state that, considering the small cohort of patients, the addition of a surgical procedure to LVFWR repair does not negatively affect early outcomes and that this mainly depends on the clinical state at presentation.
We observed no correlation between interval from AMI to LVFWR diagnosis and onset of LVFWR symptoms to surgical intervention in terms of survival. We posit that the relatively high in-hospital mortality could be connected with late presentation (>10 h), but when we considered in the analysis a shorter presentation point, such as >5 h and <10 h from the onset of symptoms, no differences were noted between survivors and non-survivors. We speculate that in our experience, survival was affected by the haemodynamic status at presentation, which represents the only independent predictor of in-hospital mortality, rather than by the time between the onset of symptoms and the operation. Thus, in-hospital mortality was significantly higher in patients with prehospitalization cardiac arrest or cardiogenic/obstructive shock. This observation accentuates the need for early diagnosis, prompt management of haemodynamic instability and institution of modalities to reduce the incidence of cardiogenic shock or cardiac arrest.
Limitations
This is a retrospective clinical study with a small cohort size. Larger patient numbers would be necessary for definitive conclusions, especially in answering the clinical questions of management superiority or procedural safety and intervention-disease outcome correlation. Multicentre registries could be useful to evaluate the efficacy of surgical management. Moreover, multivariable analysis could give limited information, because some covariates of univariable analysis were not entered in multivariable analysis because of lack of power. Nevertheless, in multivariable analysis, only cardiac arrest at presentation was an independent predictor of in-hospital mortality and this appears to be quite realistic in the real world.
CONCLUSIONS
LVFWR is a devastating complication of myocardial infarction, and without surgical treatment mortality rates as high as 80% have been reported [3] . Although the literature is replete with relatively high in-hospital mortality, there are encouraging data on both short-term and long-term clinical results. In our study, despite the fact that in-hospital survival does not exceed 66%, long-term follow-up of survivors shows excellent results approximating 75% survival at 10 years. Better early and long-term survival may be obtained on early diagnosis and prompt management of cardiogenic shock. Cardiac arrest at presentation is a poor independent prognostic factor.
